Literature DB >> 14513251

[Initial skin manifestations of Wegener's disease].

M Klammer1, G R Hetzel, G Fürst, H E Gabbert, M Megahed, T Ruzicka, U R Hengge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14513251     DOI： 10.1007/s00105-003-0597-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  16 in total

1.  Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies.

Authors:  C M Lockwood; S Thiru; S Stewart; G Hale; J Isaacs; P Wraight; J Elliott; H Waldmann
Journal:  QJM       Date:  1996-12

2.  Stage-adapted treatment of Wegener's granulomatosis. First results of a prospective study.

Authors:  D Steppat; W L Gross
Journal:  Klin Wochenschr       Date:  1989-07-03

Review 3.  Immunopathology of ANCA-associated vasculitis.

Authors:  E Csernok; A Müller; W L Gross
Journal:  Intern Med       Date:  1999-10       Impact factor: 1.271

4.  Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom.

Authors:  R A Watts; S E Lane; G Bentham; D G Scott
Journal:  Arthritis Rheum       Date:  2000-02

5.  Cyclosporin for the prevention of disease reactivation in relapsing ANCA-associated vasculitis.

Authors:  M Haubitz; K M Koch; R Brunkhorst
Journal:  Nephrol Dial Transplant       Date:  1998-08       Impact factor: 5.992

6.  Cutaneous manifestations of Wegener granulomatosis.

Authors:  C H Hu; S O'Loughlin; R K Winkelmann
Journal:  Arch Dermatol       Date:  1977-02

7.  Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis.

Authors:  B Nölle; U Specks; J Lüdemann; M S Rohrbach; R A DeRemee; W L Gross
Journal:  Ann Intern Med       Date:  1989-07-01       Impact factor: 25.391

Review 8.  Conventional treatment and outcome of Wegener's granulomatosis and microscopic polyangiitis.

Authors:  David R W Jayne
Journal:  Cleve Clin J Med       Date:  2002       Impact factor: 2.321

9.  Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis.

Authors:  C Talar-Williams; Y M Hijazi; M M Walther; W M Linehan; C W Hallahan; I Lubensky; G S Kerr; G S Hoffman; A S Fauci; M C Sneller
Journal:  Ann Intern Med       Date:  1996-03-01       Impact factor: 25.391

10.  Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease.

Authors:  E Reinhold-Keller; K De Groot; H Rudert; B Nölle; M Heller; W L Gross
Journal:  QJM       Date:  1996-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.